Market closed
$
16.33
Change
+0.22 +1.37%
Volume
Volume 332,468
Jan 20, 2021, 3:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 16.11
$ 16.33
Change
+0.22 +1.37%
Day low
Day high
$16.18
$16.33

52 week low
52 week high
$11.75
$21.49

Market cap
$63.16B
Average volume
618,790
P/E ratio
N/A
Rev. per Employee
$469,426
EPS
-2.68
Dividend
0.76
Div yield
3.25%
Ex dividend date
4/29/20
MarketWatch News on BAYRY
-
With Rare Speed, Gene Editing Emerges as Biotech’s New Cutting Edge
- Barron's Online
-
Bayer's new prostate cancer drug beats sales view
- MarketWatch.com
-
Bayer to partner with CureVac on COVID-19 vaccine
- MarketWatch.com
-
Bayer launches cell and gene therapy platform
- MarketWatch.com
-
Stocks Close Higher on Stimulus Hopes, Manufacturing Data
- Barron's Online
-
Bayer to raise $1.65B through Elanco share sale
- MarketWatch.com
-
Elanco Animal Health Stock Stumbles After Earnings Report
- Barron's Online
-
Bayer Posts $3 Billion Loss and Says Roundup Settlement Costs to Rise
- Barron's Online
-
Bayer backs 2020 outlook, but posts loss
- MarketWatch.com
-
George Floyd’s Death Leads to a Surge of New Black Board Members
- Barron's Online
-
Bayer Is Betting on Gene Therapy With a $4 Billion U.S. Acquisition
- Barron's Online
-
Bayer to pay up to $4 billion for Asklepios Bio
- MarketWatch.com
-
Bayer late lymphoma study meets primary endpoint
- MarketWatch.com
-
Stocks Close Up Slightly as Stimulus Talks Falter
- Barron's Online
-
Bayer Stock Tumbles on Profit Warning and Cost Cuts as Covid-19 Bites
- Barron's Online
-
Bayer unveils billions in new cost cuts
- MarketWatch.com
-
- MarketWatch.com
-
Dow Turns Positive for the Year as the Dollar Falls
- Barron's Online
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For July 3, 2017
- Benzinga.com
-
6 Deals Are Live In Chemical Sector: Where Do They Stand?
- Benzinga.com
Other News on BAYRY
-
Merck/Bayer's Verquvo OK'd in U.S. for chronic heart failure
- Seeking Alpha
-
Bayer to examine the production of CureVac’s COVID-19 jab
- Seeking Alpha
-
Siemens: A Fairly Priced Industry Leader
- Seeking Alpha
-
CureVac, Bayer agree to COVID-19 vaccine alliance - report
- Seeking Alpha
-
Bayer At Its Cheapest In A Decade
- Seeking Alpha
-
Agriculture Industry Bets on Carbon as a New Cash Crop
- Jacob Bunge
-
Calyxt To Exit Farming Operations And Focus On Seed Science
- Seeking Alpha
- Loading more headlines...
Press Releases on BAYRY
-
Global cancer immunotherapy market valuation to cross USD 1 billion by 2026
- Market Insight Reports
-
Organic Farming Market Views: Taking A Nimble Approach To 2021
- Market Insight Reports
-
Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)
- BusinessWire - BZX
-
Animal Parasiticides Market Size to Register 7.2% CAGR Through 2027
- Market Insight Reports
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com